Literature DB >> 2170815

Tn552, a novel transposable element from Staphylococcus aureus.

S J Rowland1, K G Dyke.   

Abstract

Tn552, one of several closely related beta-lactamase-encoding transposons from Staphylococcus aureus, has a novel set of putative transposition functions. Each is homologous with a well-characterized function from a different type of mobile genetic element. Thus, Tn552 encodes: (i) resL-binL, a co-integrate resolution system homologous with those of Tn3 family elements; (ii) p480, a potential transposase significantly homologous with the DNA integrases of eukaryotic retroviruses and retrotransposons; and (iii) p271, a potential ATP-binding protein that shows homology with the B protein of phage Mu. The 3' terminal nucleotides of Tn552 (CA), adjacent to which p480 might cleave, are the same as those of retroviruses, retrotransposons and phage Mu. The presumptive resolvase (BinL) is very closely related to BinR, which was identified as a DNA invertase and is now shown to resolve an artificial co-integrate in vivo. Furthermore, the structure of the derivative of Tn552 found in the staphylococcal plasmid pI258 can be explained by a BinL (or BinR)-mediated site-specific deletion ('resolution') event. Thus, pI258 contains only the right-hand half of Tn552, which encodes the beta-lactamase and two regulatory proteins. The latter are homologous with the beta-lactamase gene repressor and co-inducer of Bacillus licheniformis. Interestingly, the order of the regulatory genes is reversed in S. aureus compared with Bacillus licheniformis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170815     DOI: 10.1111/j.1365-2958.1990.tb00669.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  83 in total

1.  Transient promoter formation: a new feedback mechanism for regulation of IS911 transposition.

Authors:  G Duval-Valentin; C Normand; V Khemici; B Marty; M Chandler
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

2.  Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection.

Authors:  L Li; J M Olvera; K E Yoder; R S Mitchell; S L Butler; M Lieber; S L Martin; F D Bushman
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

3.  Correlation between regulation of mecA transcription and expression of methicillin resistance in staphylococci.

Authors:  C Ryffel; F H Kayser; B Berger-Bächi
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

4.  Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro.

Authors:  A Engelman; R Craigie
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

5.  Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases.

Authors:  J Kulkosky; K S Jones; R A Katz; J P Mack; A M Skalka
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

Review 6.  Beta-lactamase-producing enterococci.

Authors:  B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

7.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

8.  Arrayed transposase-binding sequences on the ends of transposon Tn5090/Tn402.

Authors:  M Kamali-Moghaddam; L Sundström
Journal:  Nucleic Acids Res       Date:  2001-02-15       Impact factor: 16.971

9.  Comparison of multiple molecular dynamics trajectories calculated for the drug-resistant HIV-1 integrase T66I/M154I catalytic domain.

Authors:  Alessandro Brigo; Keun Woo Lee; Gabriela Iurcu Mustata; James M Briggs
Journal:  Biophys J       Date:  2005-03-11       Impact factor: 4.033

10.  In vivo analysis of the plasmid pAM beta 1 resolution system.

Authors:  L Jannière; S McGovern; C Pujol; M A Petit; S D Ehrlich
Journal:  Nucleic Acids Res       Date:  1996-09-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.